chrisvoncsefalvay/vaers-outcomes huggingface dataset:
When i took the first does, i passed out the morning after the vaccine and had fever for 2 days.  I also had body ache and a light cough. The second dose, i had sever chills starting within 3 hours of the injections.  Thru out the night i was freezing but my skin was hot to the touch and i had a fever.  The second day i was very sensitive to light and sounds.  I couldn't keep my eyes open and had no energy to do anything.  I had chills the whole day.  I was bundled in 3 blanket and still shivering.   The following day i couldn't remember the event of the prior day. It felt as if i was in fog the whole day.  Note: I have COVID end of January 2021
The following day pt developed muscle and joint pains/aches that progressed and led to full eval and eventual diagnosis 9 weeks later of polymyalgia rheumatica with response to oral prednisone and resolution of sx. pt is still on prednisone.
Received expired dose of boostrix; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 12-year-old female patient who received DTPa (Reduced antigen) (Boostrix) (batch number 224CG, expiry date 07-MAY-2023) for prophylaxis.   On an unknown date, the patient received Boostrix. On an unknown date, an unknown time after receiving Boostrix, the patient experienced expired vaccine used (Verbatim: Received expired dose of boostrix). The outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 15-JUN-2023 The reporter was a medical assistant. The patient received a Boostrix which was already expired, which led to expired vaccine used. The reporter did consent to follow up.
VACCINES WERE GIVEN IN LEFT THIGH IM, THIRTY MINUTES AFTER VACCINES WERE GIVEN CHILDS LEFT THIGH SWELLED AND WAS RED AND HOT TO TOUCH. CHILD ALSO CRIED FOR THIRTY MINS NON STOP WITHOUT BEING ABLE TO BE CONSOLED.
Swelling, redness about 4 hours after shot. It then dissipated by friday (4 days later). Then on 3/24 the spot got red dots and a little itchy. The next day 3/25 the spot is raised and swollen again.
I received my first dose of the Moderna Covid 19 Vaccine on 14 May 2021. I was fine all day, but around 8pm that evening I started getting extreme chills and felt absolutely terrible. I went to bed around 10pm and tossed and turned until 3:30 in the morning. At that time I woke up in an extreme sweat and wishing for death to put an end to the pain and misery; I assume I had a fever. I took some Tylenol and that did the trick to break the fever enough to allow me to get some sleep. The following night was slightly better, but I was still miserable. I received my second dose of the Moderna Covid 19 Vaccine at a grocery store, on 11 June 2021. Again, I felt fine for the day, but at about 8pm I started feeling terrible again. Chills, aches, sweating?. This time we had a thermometer in the house and I clocked in at a fever of 102.8 by 10pm. I took some Iburophen which helped but I ultimately had a long miserable night, again. I was drained and miserable the next day. The following evening, I once again had a fever of 101.8 and took Ibuprophen again to help. It took several days for me to recover to feeling decent.   My family and I went on a camping trip and tent camped for three days in June. I returned to another city on 21 June and after taking a shower my whole body became inflamed, glowed red from irritation, and I experienced itching all over my body; It was terrifying. If I had an itch anywhere on my body, and scratched it, it would inflame into a welt and stay inflamed for at least 15 minutes, sometimes longer. I dealt with this for over a week, until I went to a doctor in a town and was diagnosed with Urticaria. I was prescribed 180mg Allegra which I started taking one day later after it was approved by my flight doctor back at a military base. It lessened the irritation, but the inflammation remained. Even to this day, 13 August 2021, I am dealing with skin irritation that inflames after the slightest touch/itch. The Allegra seems to help lessen the inflammation, but it is still very much an issue.
Patient reported developing a large, itchy, red, rash with raised hives across her chest/stomach. Lasted about a week.
Staff member felt muscle twitching sporadically 1-2x starting 10 minutes after vaccination.  1.5 hours after vaccination, staff felt tingling/numbing sensation from injection site down into fingers.  No adverse events felt above injection site at this time.
Drank some herbal tea 30 minutes after last dose of Vivotif; Spontaneous report received on 13DEC2019.  A female consumer reported that she "drank some herbal tea 30 minutes after taking the last dose of Vivotif" (PT: Product administration error) while being on oral Vivotif for typhoid fever prophylaxis. One year before reporting, the consumer took all four doses of Vivotif but she drank some herbal tea 30 minutes after taking her last dose. Action taken with Vivotif with respect to the reported event was not applicable. The outcome of the reported event was unknown.  Company Comment: A consumer drank some herbal tea 30 minutes after taking the last dose of Vivotif (Product administration error). Considering the nature of the event, the causality is assessed as not related to Vivotif.; Sender's Comments: A consumer drank some herbal tea 30 minutes after taking the last dose of Vivotif (Product administration error). Considering the nature of the event, the causality is assessed as not related to Vivotif.
Possible SIDS 4/25/08-COD Sudden Infant Death Syndrome
UNSPECIFIED ADVERSE EVENT; This spontaneous report received from a social media via company representative concerned a 38 year old of unspecified sex. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included the patient was on more medication due to event. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date, the subject experienced unspecified adverse event. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from unspecified adverse event. This report was non-serious.; Sender's Comments: V0:Medical assessment comments not required as per standard procedure, as the case is assessed non serious.
Herpes Zosters Shingles (Acute); This spontaneous case was reported by a physician and describes the occurrence of HERPES ZOSTER (Herpes Zosters Shingles (Acute)) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Nov-2021, the patient experienced HERPES ZOSTER (Herpes Zosters Shingles (Acute)). At the time of the report, HERPES ZOSTER (Herpes Zosters Shingles (Acute)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment details were reported.   Reporter did not allow further contact
Pain at site of injection; Severe pain upper spine by base of skull; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 53 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 03Jul2021 10:15 (Lot number: EW0196) at the age of 53 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Diabetes" (unspecified if ongoing); "Sarcoidosis" (unspecified if ongoing). Concomitant medication(s) included: INSULIN. The following information was reported: INJECTION SITE PAIN (non-serious) with onset 04Jul2021 06:00, outcome "not recovered", described as "Pain at site of injection"; SPINAL PAIN (non-serious) with onset 04Jul2021 06:00, outcome "not recovered", described as "Severe pain upper spine by base of skull". Therapeutic measures were not taken as a result of injection site pain, spinal pain.  Follow-up attempts are completed. No further information is expected.
No adverse reaction. Was instructed to fill out since PROQUAD was administered to an 18 year old.
really bad hives; still has some/feels a little bit, but they are not as bad; Chills; Headache; a little bit of dizziness; This is a spontaneous report from a contactable consumer (patient).   A 55-year-old male patient received BNT162B2 (PFIZER-BIOTECH COVID-19 VACCINE, solution for injection) via an unspecified route of administration, administered in arm left on 06Jul2021 16:00 (at the age of 55 years old) as dose 1, single for COVID-19 immunisation. No known medical history and concomitant medications. On 08Jul2021, the patient experienced really bad hives and still has some/feels a little bit, but they are not as bad, chills, headache, a little bit of dizziness. The patient stated that they have all improved and didn't notice these reactions until 2 days after getting the vaccine. The patient other products were reported as no. The patient history was reported as no, and the investigation assessment was reported as no. It was reported that the patient had no other vaccines given the same day or 4 weeks prior and no problems with vaccines in past. The Vaccination Facility Type was Pharmacy/Drug Store and was not administered in a military facility. The history of all previous immunization with the Pfizer vaccine considered as suspect (or patient age at first and subsequent immunizations if dates of birth or immunizations are not available) was reported as none. The Additional Vaccines Administered on Same Date of the Pfizer Suspect If applicable, list all vaccines administered on same date with the Pfizer vaccine considered as suspect was reported as none. The patient adverse events did not require a visit to the emergency room or physician office. Prior Vaccinations (within 4 weeks) If applicable, list any other vaccinations within four weeks prior to the first administration date of the suspect vaccine(s) was reported as none. There were no adverse events following prior vaccinations. The Family Medical History Relevant to adverse event and relevant tests were reported as none. The outcome of the event hives was not recovered; outcome of the events chills, headache and dizziness was recovering.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
arm is really sore now; Fever; Arm became sore; A spontaneous report was received consumer concerning a from a 85-year-old female who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced sore arm and a fever of 101.5°F.  The patient's medical history included COVID-19. Concomitant medications reported included two blood pressure pills, blood thinner, statin and vitamins.  On 30 Dec 2020, the patient received their first of two planned doses of mRNA-1273 intramuscularly in the left arm for prophylaxis of COVID-19 infection.   On 30 Dec 2020, the patient had a sore arm.   On 31 Dec 2020, patient developed a really sore arm and a fever of 101.5°F.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome event(s) sore arm and fever of 101.5°F, were unknown.; Reporter's Comments: This case concerns an 85-year-old female with PMH of OCIVD-19, who experienced NS unexpected events of pain in extremity and pain aggravated along with NS expected fever.  Event onset occurred the same day as first dose of mRNA-1273. Treated with "baby aspirin" not reported. Event outcome unknown.  Based on the current available information and temporal association between the use of the product and the start date of the event of sore arm and fever of 101.5F,  a causal relationship cannot be excluded.
Said can feel a migraine coming on; I was getting migraine headache; This is a spontaneous report from a Pfizer-sponsored program. A contactable female consumer (patient herself) of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, lot number: not reported) via an unspecified route of administration on 03Feb2021 as 1st dose, single dose for COVID-19 immunization. Medical history included migraine; she suffered from migraines, clarified had migraines before getting COVID vaccine from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. It was reported that, she received first dose of COVID vaccine yesterday and said that she could feel a migraine coming on. She was getting migraine headache on unspecified date in Feb2021. She don't want to take anything but sometimes it escalates. She wanted to know if she could take something. Therapeutic measures were taken as a result of migraine coming on and headache as currently, she was on Imitrex or the generic Sumatriptan 50 mg and she enquired would that effect it or not. The outcome of events was unknown.  Limited information was available over the call.  Information on lot and Batch number has been requested.  Follow-up attempts are completed. No further information is expected.
Fever; Chills; This spontaneous case was reported by a nurse and describes the occurrence of PYREXIA (Fever) and CHILLS (Chills) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M2OA) for COVID-19 vaccination.     The patient's past medical history included Chest discomfort, AFib on 09-Sep-2020 and COVID-19. Concurrent medical conditions included Shellfish allergy (Patient is allergic shrimp). Concomitant products included APIXABAN (ELIQUIS), CARVEDILOL, LISINOPRIL and VITAMIN D NOS for an unknown indication.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 06-Feb-2021, the patient experienced PYREXIA (Fever) and CHILLS (Chills). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 06-Mar-2021, PYREXIA (Fever) and CHILLS (Chills) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 09-Jul-2020, SARS-CoV-2 test negative: negative (Negative) Negative.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Action taken with mRNA-1273 in response to the event was not applicable.   This case was linked to MOD-2021-028450 (Patient Link).
He had fatigue, cough, and sore throat. We took him to urgent care, and they prescribed dexamethasone. He continued to get worse, so we took him to the emergency room, and he was hospitalized overnight because his asthma was flared up and they had to watch over him. They gave him prednisone and azithromycin.
Same day post vax, the pt developed redness and itching on both inner thighs. By the next evening, the entire inner thigh was covered with red almost port wine stain with raised welts, hives, and intense itching. Went to urgent care and received Benadryl IM.
pt recv vax 1DEC97 & 15DEC97 pt exp rash, arthralgia & fever;
Client received COVID Moderna 6months-5years vaccine on 7/28/2022 at 16:00, 2nd dose. Client is 3 years old. Client's father responded "no" to all other prevaccination questions. Father gave permission for vaccine and signed consent. Client moved during first vaccination attempt in right deltoid (0.07mL of vaccine was injected into right delotid). Vaccination was immediately readministered (full dose of 0.25mL) in left detoid. Client tolerated vaccination well. Advised to wait 30 minutes postvaccination. Client ambulated out of clinic independently with father after 30 minutes.
This spontaneous report was received from a pharmacist referring to a patient of unknown age and gender. No information about the patient's medical history, concurrent conditions, drug reactions or allergies and concomitant therapies was provided. On 10-JAN-2017 at 09:45, the patient was vaccinated with an improperly stored VARIVAX (lot # M031969) for prophylaxis (expiration date, dose and route of administration were not reported). It was reported that the vaccine underwent previous temperature excursions, but the number of previous excursions, time frames and values of incorrect temperature were unknown. A digital data logger was used. No adverse effects were reported. Product quality complaint was not involved. This is one of several reports received from the same reporter. Additional information has been requested.; Sender's Comments: US-009507513-1701USA008441: US-009507513-1704USA000389: US-009507513-1704USA000390: US-009507513-1704USA000391: US-009507513-1704USA000392: US-009507513-1704USA000393: US-009507513-1704USA000394: US-009507513-1704USA000395: US-009507513-1704USA000396: US-009507513-1704USA000397: US-009507513-1704USA000398: US-009507513-1704USA000399: US-009507513-1704USA000400: US-009507513-1704USA000401: US-009507513-1704USA000402: US-009507513-1704USA000403: US-009507513-1704USA000404: US-009507513-1704USA000405: US-009507513-1704USA000406: US-009507513-1704USA000407: US-009507513-1704USA000408: US-009507513-1704USA000409: US-009507513-1704USA000410: US-009507513-1704USA000411: US-009507513-1704USA000412: US-009507513-1704USA000413: US-009507513-1704USA000414: US-009507513-1704USA000415: US-009507513-1704USA000416: US-009507513-1704USA000417: US-009507513-1704USA000418: US-009507513-1704USA000419: US-009507513-1704USA000420: US-009507513-1704USA000421: US-009507513-1704USA000422: US-009507513-1704USA000423: US-009507513-1704USA000424: US-009507513-1704USA000425: US-009507513-1704USA000426: US-009507513-1704USA000427: US-009507513-1704USA000428: US-009507513-1704USA000429: US-009507513-1704USA000430: US-009507513-1704USA000431: US-009507513-1704USA000432: US-009507513-1704USA000433: US-009507513-1704USA000434: US-009507513-1704USA000435: US-009507513-1704USA000436: US-009507513-1704USA000437: US-009507513-1704USA000438: US-009507513-1704USA000439: US-009507513-1704USA000440: US-009507513-1704USA000441: US-009507513-1704USA000442: US-009507513-1704USA000444: US-009507513-1704USA000445: US-009507513-1704USA000446: US-009507513-1704USA000447: US-009507513-1704USA000448: US-009507513-1704USA000449: US-009507513-1704USA000450: US-009507513-1704USA000451: US-009507513-1704USA000452: US-009507513-1704USA000453: US-009507513-1704USA000454: US-009507513-1704USA000455: US-009507513-1704USA000456: US-009507513-1704USA000457.
Bicep tendinitis; This is spontaneous report from a non-contactable health professional, the patient. A 26-year-old non-pregnant female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot number: EL9264) via an unspecified route of administration in the left arm on an unspecified date (at the age of 26-years-old) as a single dose for COVID-19 immunization. Medical history was none, and the patient had no known allergies. The patient was not diagnosed with COVID-19 prior to vaccination. Concomitant medications were not reported. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) on an unspecified date (within 4 weeks of the second vaccination) for COVID-19 immunization. On 05Feb2021, the patient experienced bicep tendinitis with severe shooting sharp pain when extending the arm and bending over 150 degrees as well as pain which also worsened when twisting the wrist from the facing leg toward the sky. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of bicep tendinitis was not resolved.  No follow-up attempts are possible. No further information is expected.
Severe pain & inflammation at injection site for 24 hours then  unrelenting  chest pain  gradually started.  Thought it was from other sources so tried to treat independently ruling out other Dx for two weeks
ALTE choking episode about 1 hour after vaccines. Hospitalized, monitored, recovered, normal now.
Exactly 12 hours post injection, extremely intense headache behind eyes, painful teeth, temperature 101,  muscle and joint pain,  malaise.  Also, injection site discomfort.
Lost her voice for more than a month.  Recovered with Antiviral and cortical steroid regimen. Per Patient on 12/18/2014 that she is "80% better".
sinus problem (sinus pressure); itchy runny eyes; itchy runny eyes; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date were not reported), via an unspecified route of administration on 26Mar2021 as dose 1, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced sinus problem (sinus pressure) and itchy runny eyes on an unspecified date. She wants to know if she can take Benadryl. Outcome of events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Chills, headache, sinus congestion began 7/18/2021 Chest congestion and cough began 7/19/2021 Chest congestion, productive cough with thick mucus and hard white chunks began 7/21/2021 Difficulty breathing , wheezing, and continued cough 7/22/2021 First Emergency Room visit on 7/24/2021 for worsening Congestion, cough, and decreased 02 saturation. Second Emergency Room visit on 7/25/2021 for same complaint Third Emergency Room visit on 7/26/2021 for above complaints and fall from LOC
Approximately two months after second dose of vaccination began to develop rash.  Pruritic rash beginning in inguinal crease.  Subsequently slowly developed moderately extensive pruritic vessicular rash on trunk.  Similar rash slowly developed in a spotty distribution on extremities.  After puruitic vessicular phase transformed to maculopapular appearance.  Later stages formed on palms and soles of feet.
Sore arm   Midnight 01 30 am   100 Fever  early am 01 31 20     Chills same    Lite headed  same       Took  one  tylenol 325  aT midnight 01 30 am              2cd  Tylenol at 5 am  100. 9 temperature.    Took 3rd tylenol  800am      Temperature steady.   Slept.